Spyre Therapeutics (SYRE) Current Deferred Revenue (2016 - 2023)
Spyre Therapeutics posted quarterly Current Deferred Revenue of $930000.0 for Q2 2023, up 210.0% year-on-year from $300000.0 in Q2 2022, and up 207.95% on a QoQ basis from $302000.0 in Q1 2023.
Spyre Therapeutics (SYRE) has 5 years of Current Deferred Revenue data on file, last reported at $930000.0 in Q2 2023.
- For the quarter ending Q2 2023, Current Deferred Revenue rose 210.0% year-over-year to $930000.0; the trailing twelve-month figure through Jun 2023 stood at $930000.0 (up 210.0% YoY), and the FY2022 full-year result was $2.7 million, up 14.29% from the prior year.
- Current Deferred Revenue for Q2 2023 stood at $930000.0, up from $302000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $21.5 million in Q1 2021 and bottomed at $300000.0 in Q2 2022.
- The 3-year median for Current Deferred Revenue is $2.2 million (2021), against an average of $4.3 million.
- The widest annual swing landed in 2022, when Current Deferred Revenue plunged 94.55%; it then soared 210.0% in 2023.
- A 3-year view of Current Deferred Revenue shows it stood at $2.4 million in 2021, then rose by 14.29% to $2.7 million in 2022, then sank by 65.5% to $930000.0 in 2023.
- The last three Current Deferred Revenue figures came in at $930000.0 (Q2 2023), $302000.0 (Q1 2023), and $2.7 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 930,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | 505,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Sep 30, 2021 | 6.40 Mn |
| Jun 30, 2021 | 5.50 Mn |
| Mar 31, 2021 | 21.50 Mn |
| Dec 31, 2017 | 20,000.00 |
| Sep 30, 2017 | 50,000.00 |
| Jun 30, 2017 | 71,000.00 |
| Mar 31, 2017 | 51,000.00 |
| Dec 31, 2016 | 71,000.00 |
| Sep 30, 2016 | 181,000.00 |